Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayle Ross

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
ISRN Dermatology|February 25, 2012
Photodynamic therapy for Basal cell carcinoma in recessive dystrophic epidermolysis bullosaMyn Wee Lee, George Varigos, Peter Foley, et al.
The Australasian Journal of Dermatology|December 29, 2025
Dual Dupilumab and Omalizumab Therapy in Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma: Real-World Experience From an Eight-Patient Case SeriesJessica McClatchy, Vanessa Morgan, Laura Scardamaglia, et al.
Australian Journal of General Practice|August 4, 2025
Skin erosions and abnormal liver functionYuan-Jessica Zhuang, Andrew Awad, Ashok S Raj, et al.
The Australasian Journal of Dermatology|May 25, 2011
Haem arginate as effective maintenance therapy for hereditary coproporphyriaEllen Ma, Victoria Mar, George Varigos, et al.
Case Reports in Dermatological Medicine|February 25, 2026
Urothelial Carcinoma of the Penile Urethra as a Potential Secondary Complication of Junctional Epidermolysis Bullosa: A Case Report and Review of the LiteratureJessica McClatchy, Ingrid Winship, Laura Scardamaglia, et al.
Archives of Dermatology|August 19, 2009
Antioxidant effect of warfarin therapy: a possible symptomatic treatment for erythropoietic protoporphyriaIngrid Winship, Gayle Ross, Amanda Nicoll, et al.
Clinical and Experimental Dermatology|January 13, 2026
An open-label phase II study of bitopertin in adults and adolescents with erythropoietic protoporphyria or X-linked protoporphyriaGayle Ross, Peter Stewart, George Mensing, et al.
JIMD Reports|December 11, 2025
Liver Transplantation and Other Hepatically Directed Therapies Do Not Change the Biochemical Phenotype nor Halt Progression of Leukodystrophy due to Biallelic <i>HMBS</i> Variants: A Case ReportJeremy Clark, Joel Smith, Yoke Leong, et al.
The Australasian Journal of Dermatology|November 19, 2025
A Meta-Analysis of the Prevalence of Mismatch Repair Germline Mutations in Patients With Sebaceous Neoplasms: Are We Missing an Opportunity for Lynch Syndrome Detection?Nadine Abu-Ghazaleh, Dalyia Abu-Ghazaleh, Rebecca Jerjen, et al.
The Australasian Journal of Dermatology|March 28, 2019
Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyriaBrent J Doolan, Mi Vu, George A Varigos, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
ISRN Dermatology|February 25, 2012
Photodynamic therapy for Basal cell carcinoma in recessive dystrophic epidermolysis bullosaMyn Wee Lee, George Varigos, Peter Foley, et al.
The Australasian Journal of Dermatology|December 29, 2025
Dual Dupilumab and Omalizumab Therapy in Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma: Real-World Experience From an Eight-Patient Case SeriesJessica McClatchy, Vanessa Morgan, Laura Scardamaglia, et al.
Australian Journal of General Practice|August 4, 2025
Skin erosions and abnormal liver functionYuan-Jessica Zhuang, Andrew Awad, Ashok S Raj, et al.
The Australasian Journal of Dermatology|May 25, 2011
Haem arginate as effective maintenance therapy for hereditary coproporphyriaEllen Ma, Victoria Mar, George Varigos, et al.
Case Reports in Dermatological Medicine|February 25, 2026
Urothelial Carcinoma of the Penile Urethra as a Potential Secondary Complication of Junctional Epidermolysis Bullosa: A Case Report and Review of the LiteratureJessica McClatchy, Ingrid Winship, Laura Scardamaglia, et al.
Archives of Dermatology|August 19, 2009
Antioxidant effect of warfarin therapy: a possible symptomatic treatment for erythropoietic protoporphyriaIngrid Winship, Gayle Ross, Amanda Nicoll, et al.
Clinical and Experimental Dermatology|January 13, 2026
An open-label phase II study of bitopertin in adults and adolescents with erythropoietic protoporphyria or X-linked protoporphyriaGayle Ross, Peter Stewart, George Mensing, et al.
JIMD Reports|December 11, 2025
Liver Transplantation and Other Hepatically Directed Therapies Do Not Change the Biochemical Phenotype nor Halt Progression of Leukodystrophy due to Biallelic <i>HMBS</i> Variants: A Case ReportJeremy Clark, Joel Smith, Yoke Leong, et al.
The Australasian Journal of Dermatology|November 19, 2025
A Meta-Analysis of the Prevalence of Mismatch Repair Germline Mutations in Patients With Sebaceous Neoplasms: Are We Missing an Opportunity for Lynch Syndrome Detection?Nadine Abu-Ghazaleh, Dalyia Abu-Ghazaleh, Rebecca Jerjen, et al.
The Australasian Journal of Dermatology|March 28, 2019
Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyriaBrent J Doolan, Mi Vu, George A Varigos, et al.
Pageof 4